Novel Inflammatory Biomarkers as Additional Value to Traditional Risk-factors in Cardiovascular Risk Stratification

3 Novel and Traditional Cardiovascular Risk Factors in Adolescents

The Role of Carotid Ultrasound for Cardiovascular Risk Stratification beyond Traditional Risk Factors

Primary prevention and early detection of cardiovascular disease is important, as it is the leading cause of death throughout world. Risk stratification algorithms, such as Framingham Risk Score and European Systematic Coronary Risk Evaluation, that utilize a combination of various traditional risk factors have been developed to improve primary prevention. However, the accuracy of these algorit...

Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification.

BACKGROUND Menopausal hormone therapy (HT) continues to have a clinical role in symptom management, but identifying women for whom benefits will outweigh the risks remains a challenge. Although hormone therapy (HT) is the most effective strategy for ameliorating vasomotor and other symptoms, randomized clinical trials show an unfavorable balance of benefits and risks for many women. However, cl...

Evaluating new cardiovascular risk factors for risk stratification.

Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians

The increasing pressure on health resources has led to the emergence of risk assessment as an essential tool in the management of cardiovascular disease (CVD). Concern exists regarding the validity of their generalization to all populations. Existing risk scoring models do not incorporate emerging 'novel' risk factors. In this context, the aim of the study was to examine the relevance of Britis...